ArticleThe protein journal2025
Unveiling the Immunostimulatory Potential of the HSPA1A Mini-Chaperones Compared to the HSPA1A and HSP27 Chaperones: In Silico and In Vitro Insights for Vaccine Development.
Article in The protein journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular chaperones known as heat shock proteins (HSPs) are evolutionarily conserved and are critical in regulating immune system functions. To assess the immunostimulatory potential of HSPs, we employed advanced computational and experimental techniques. Bioinformatics tools were employed to analyze and confirm the physicochemical characteristics of the full-length HSPA1A, the fragments of HSPA1A known as minichaperones (C-terminal region of HSPA1A: CHSPA1A and N-terminal region of HSPA1A: NHSPA1A), and the full length HSP27, confirming their advantageous properties and structural integrity through 3D refinement and validation. Docking studies revealed significant interactions of HSPs with CD91 and TLR4 receptors respectively, notably a strong and stable binding of the full length HSPA1A and CHSPA1A with CD91. Molecular dynamics simulations were conducted to confirm the structural stability of the complexes formed between HSPs and CD91. Immunological simulations demonstrated robust and stable responses from both innate and adaptive immune cells against HSPs. All HSPs were produced in E. coli, isolated via Ni-NTA affinity chromatography, and subsequently utilized to stimulate immune cells from mice in vitro. The results showed significant secretion of TNF-α and IFN-γ in comparison to IL-10, indicating a directed T-helper 1 (cellular) immunity. The in silico and in vitro findings represented that HSPA1A and then CHSPA1A resulted in significantly greater TNF-α secretion in splenocytes co-cultured with the pulsed DCs compared to NHSPA1A and HSP27, suggesting their significant role in activating adaptive immunity. In contrast, macrophages exhibited an increased TNF-α secretion in response to HSP27, suggesting its involvement in modulating innate inflammatory processes. Understanding these differences can help in designing more effective immunotherapies.
Indexed as
Identifiers
40813535What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.